Healthcare provider profile · identity verified

Sylvia Simmons, NP

Nurse Practitioner · NEW YORK, NY · NPI 1881845600

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	552	65
Amlodipine Besylate	Amlodipine Besylate	500	53
Gabapentin	Gabapentin	404	47
Metformin Hcl	Metformin Hcl	361	37
Tamsulosin Hcl	Tamsulosin Hcl	277	29
Metoprolol Succinate	Metoprolol Succinate	266	34
Lisinopril	Lisinopril	259	27
Rosuvastatin Calcium	Rosuvastatin Calcium	252	27
Pantoprazole Sodium	Pantoprazole Sodium	238	28
Eliquis	Apixaban	188	24
Levothyroxine Sodium	Levothyroxine Sodium	187	18
Furosemide	Furosemide	175	20
Pravastatin Sodium	Pravastatin Sodium	172	19
Quetiapine Fumarate	Quetiapine Fumarate	172	17
Latanoprost	Latanoprost	166	18
Mirtazapine	Mirtazapine	147	16
Losartan Potassium	Losartan Potassium	144	22
Jardiance	Empagliflozin	135	16
Hydrochlorothiazide	Hydrochlorothiazide	133	16
Carvedilol	Carvedilol	126	14
Clopidogrel	Clopidogrel Bisulfate	117	13
Ozempic	Semaglutide	116	13
Finasteride	Finasteride	115	suppressed
Levetiracetam	Levetiracetam	113	suppressed
Donepezil Hcl	Donepezil Hcl	112	12
Metoprolol Tartrate	Metoprolol Tartrate	112	14
Trazodone Hcl	Trazodone Hcl	101	suppressed
Hydralazine Hcl	Hydralazine Hcl	97	suppressed
Memantine Hcl	Memantine Hcl	94	suppressed
Risperidone	Risperidone	86	suppressed
Ezetimibe	Ezetimibe	85	suppressed
Glipizide	Glipizide	84	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	80	suppressed
Famotidine	Famotidine	78	12
Fluoxetine Hcl	Fluoxetine Hcl	78	suppressed
Nifedipine Er	Nifedipine	77	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	75	suppressed
Potassium Chloride	Potassium Chloride	73	suppressed
Duloxetine Hcl	Duloxetine Hcl	72	suppressed
Sertraline Hcl	Sertraline Hcl	71	suppressed
Chlorthalidone	Chlorthalidone	66	suppressed
Tramadol Hcl	Tramadol Hcl	66	11
Ammonium Lactate	Ammonium Lactate	65	17
Memantine Hcl Er	Memantine Hcl	61	suppressed
Novolog Flexpen	Insulin Aspart	58	suppressed
Benztropine Mesylate	Benztropine Mesylate	57	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	57	suppressed
Montelukast Sodium	Montelukast Sodium	56	suppressed
Januvia	Sitagliptin Phosphate	55	suppressed
Citalopram Hbr	Citalopram Hydrobromide	54	suppressed
Meloxicam	Meloxicam	54	suppressed
Allopurinol	Allopurinol	53	suppressed
Atenolol	Atenolol	53	suppressed
Myrbetriq	Mirabegron	52	suppressed
Spironolactone	Spironolactone	49	suppressed
Baclofen	Baclofen	48	suppressed
Simvastatin	Simvastatin	48	suppressed
Olanzapine	Olanzapine	47	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	46	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	45	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	43	suppressed
Pregabalin	Pregabalin	42	suppressed
Divalproex Sodium Er	Divalproex Sodium	41	suppressed
Haloperidol	Haloperidol	41	suppressed
Omeprazole	Omeprazole	40	suppressed
Valsartan	Valsartan	40	suppressed
Alendronate Sodium	Alendronate Sodium	37	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	36	20
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	36	suppressed
Labetalol Hcl	Labetalol Hcl	35	suppressed
Amantadine	Amantadine Hcl	33	suppressed
Glipizide Er	Glipizide	31	suppressed
Nystatin	Nystatin	30	13
Oxycodone Hcl	Oxycodone Hcl	29	suppressed
Torsemide	Torsemide	29	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	28	suppressed
Farxiga	Dapagliflozin Propanediol	28	suppressed
Naltrexone Hcl	Naltrexone Hcl	28	suppressed
Tradjenta	Linagliptin	28	suppressed
Tresiba Flextouch U-100	Insulin Degludec	28	suppressed
Breo Ellipta	Fluticasone/Vilanterol	27	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	27	suppressed
Bupropion Xl	Bupropion Hcl	27	suppressed
Gemtesa	Vibegron	27	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Prednisolone Acetate	Prednisolone Acetate	27	suppressed
Buspirone Hcl	Buspirone Hcl	26	suppressed
Enalapril Maleate	Enalapril Maleate	26	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	26	suppressed
Prednisone	Prednisone	26	suppressed
Trospium Chloride	Trospium Chloride	26	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	26	suppressed
Ranolazine Er	Ranolazine	25	suppressed
Acetazolamide	Acetazolamide	24	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	24	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	23	suppressed
Combigan	Brimonidine Tartrate/Timolol	21	suppressed
Ramelteon	Ramelteon	21	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Incruse Ellipta	Umeclidinium Bromide	19	suppressed
Aripiprazole	Aripiprazole	18	suppressed
Entresto	Sacubitril/Valsartan	18	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	18	suppressed
Divalproex Sodium	Divalproex Sodium	17	suppressed
Estradiol	Estradiol	17	suppressed
Haloperidol Decanoate	Haloperidol Decanoate	17	suppressed
Lacosamide	Lacosamide	17	suppressed
Lamotrigine	Lamotrigine	17	suppressed
Tivicay	Dolutegravir Sodium	17	suppressed
Trulicity	Dulaglutide	16	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	15	suppressed
Lumigan	Bimatoprost	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Risperidone Er	Risperidone Microspheres	14	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	14	suppressed
Ssd	Silver Sulfadiazine	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	13	suppressed
Anastrozole	Anastrozole	13	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Etravirine	Etravirine	13	suppressed
Humira(Cf) Pen	Adalimumab	13	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	13	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	13	suppressed
Novolog	Insulin Aspart	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	13	suppressed
Synjardy	Empagliflozin/Metformin Hcl	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	12	suppressed
Darunavir	Darunavir	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Methotrexate	Methotrexate Sodium	12	suppressed
Oxcarbazepine	Oxcarbazepine	12	suppressed
Rasuvo	Methotrexate/Pf	12	suppressed
Tresiba Flextouch U-200	Insulin Degludec	12	suppressed
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Carbidopa-Levodopa-Entacapone	Carbidopa/Levodopa/Entacapone	11	suppressed
Colchicine	Colchicine	11	suppressed
Lithium Carbonate Er	Lithium Carbonate	11	suppressed
Niacin Er	Niacin	11	suppressed
Paliperidone Er	Paliperidone	11	suppressed
Risperidone Odt	Risperidone	11	suppressed
Rybelsus	Semaglutide	11	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error